the Use of Tranexamic Acid to Prevent the Bleeding in Bariatric Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2025

Conditions
HaemorrhageBariatric Surgery Candidate
Interventions
DRUG

tranexamic acid (1 g diluted in 100 mL of 0.9% saline

The pharmacist also prepared indistinguishable infusion bags containing tranexamic acid (1 g diluted in 100 mL of 0.9% saline) . The infusion was administered intravenously over 10-15 minutes immediately after induction of anesthesia and before skin incision, at a maximum rate of 100 mg per minute

DRUG

placebo (100 mL of 0.9% saline).

The pharmacist also prepared indistinguishable infusion bags containing placebo (100 mL of 0.9% saline). The infusion was administered intravenously over 10-15 minutes immediately after induction of anesthesia and before skin incision, at a maximum rate of 100 mg per minute

Trial Locations (1)

1714

Cairo University, Giza

All Listed Sponsors
lead

Cairo University

OTHER

NCT07187258 - the Use of Tranexamic Acid to Prevent the Bleeding in Bariatric Surgery | Biotech Hunter | Biotech Hunter